... A dataset was provided by the spon-sor (Abbott, Abbott Park, IL, USA) to the FDA, contain-ing data from 14 clinical trials conducted to evaluate theefficacy and safety of DVPX in various indications. ... abuse,electroconvulsive therapy, and residing in mental institution;history of obesity, diabetes, cardiovascular disease; SADS-C rated as2 (slight) on day 15 and 4 (moderate) on day 30.ManiamaintenanceDVPX ... lasting 6 hours after a ‘family event’.SADS-C rated as 0 (not at all) on day -1 and day 5.ManiamaintenanceDVPX 24 52 Male Depression Moderate suicidal ideation. Family history of suicide, abuse,electroconvulsive...